Mosaic ImmunoEngineering (CPMV) Non Operating Interest Expenses (2010 - 2026)

Mosaic ImmunoEngineering has reported Non Operating Interest Expenses for 5 years, with the latest figure at $2467.0 in Q1 2026.

• On a quarterly basis, Non Operating Interest Expenses changed 0.04% year-over-year to $2467.0 in Q1 2026; TTM through Mar 2026 was $10002.0, a 20.7% increase from a year earlier, with the FY2025 full-year figure at $10001.0, up 43.82% from the prior year.
• Non Operating Interest Expenses was $2467.0 for Q1 2026 at Mosaic ImmunoEngineering, down from $2521.0 in the prior quarter.
• The five-year high for Non Operating Interest Expenses was $3004.0 in Q4 2024, with the low at $2466.0 in Q1 2025.
• Average Non Operating Interest Expenses over 3 years is $2612.7, with a median of $2521.0 recorded in 2025.
• The sharpest annual moves came in 2025 and 2026: Non Operating Interest Expenses dropped 16.08% in 2025, then rose 0.04% in 2026.
• Over 3 years, Non Operating Interest Expenses stood at $3004.0 in 2024, then decreased by 16.08% to $2521.0 in 2025, then declined by 2.14% to $2467.0 in 2026.
• The last three Non Operating Interest Expenses figures came in at $2467.0 (Q1 2026), $2521.0 (Q4 2025), and $2521.0 (Q3 2025), per Business Quant data.